Ingersoll Rand Inc.·4

Feb 19, 6:31 PM ET

Scheske Michael J 4

4 · Ingersoll Rand Inc. · Filed Feb 19, 2026

Research Summary

AI-generated summary of this filing

Updated

Ingersoll Rand VP Michael Scheske Exercises Options, Sells Shares

What Happened Michael J. Scheske, Vice President and Chief Accounting Officer of Ingersoll Rand (IR), exercised stock options on 2026-02-17 to acquire a total of 19,122 shares (11,479 shares and 7,643 shares) and then sold those 19,122 shares in same-day open-market transactions. He paid aggregate exercise prices of $667,369 (11,479 @ $27.79 = $319,001; 7,643 @ $45.58 = $348,368) and received gross proceeds of $1,867,562 from the sales (11,479 @ $97.11 = $1,114,726; 7,643 @ $98.50 = $752,836). The sales followed the option exercises, consistent with a cashless exercise and immediate disposition.

Key Details

  • Transaction date: 2026-02-17; Form 4 filed 2026-02-19 (timely).
  • Option exercises: 11,479 shares @ $27.79 and 7,643 shares @ $45.58 (total paid $667,369).
  • Open-market sales: 11,479 shares @ $97.11 and 7,643 shares @ $98.50 (total proceeds $1,867,562).
  • Footnote: F1 — the stock options exercised were fully vested and exercisable.
  • Shares owned after transaction: not specified in the provided filing.

Context

  • This was an option exercise followed by immediate sale of the acquired shares (cashless exercise), a common way executives realize value from vested options. The filing shows both the acquisition via exercise (derivative transaction code M) and the subsequent open-market sales (code S).
  • The transactions are routine insider liquidity and do not by themselves indicate the insider’s long-term view of the company.

Insider Transaction Report

Form 4
Period: 2026-02-17
Scheske Michael J
VP, Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-17$27.79/sh+11,479$319,00123,632.179 total
  • Sale

    Common Stock

    2026-02-17$97.11/sh11,479$1,114,72612,153.179 total
  • Exercise/Conversion

    Common Stock

    2026-02-17$45.58/sh+7,643$348,36819,796.179 total
  • Sale

    Common Stock

    2026-02-17$98.50/sh7,643$752,83612,153.179 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    [F1]
    2026-02-1711,4790 total
    Exercise: $27.79Exp: 2030-03-06Common Stock (11,479 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    [F1]
    2026-02-177,6430 total
    Exercise: $45.58Exp: 2031-02-23Common Stock (7,643 underlying)
Footnotes (1)
  • [F1]These stock options are fully vested and exercisable.
Signature
/s/ Andrew Schiesl, as Attorney-in-Fact|2026-02-19

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4